DEA Under Scrutiny for Allowing Fentanyl Shipments in New Mexico During Investigations
The DEA faces scrutiny after an AP investigation revealed agents allegedly allowed hundreds of thousands of fentanyl pills into New Mexico communities (2023-2025) while building cases against drug trafficking networks. Critics cite public safety risks due to fentanyl's potency, while the DEA defends its actions as lawful intelligence gathering targeting major organizations.
















